News
01-14-2021, 11:36 PM
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
More... (https://www.news-medical.net/news/20210115/Targeting-RNA-splicing-can-activate-antiviral-immune-pathways-in-triple-negative-breast-cancers.aspx)
More... (https://www.news-medical.net/news/20210115/Targeting-RNA-splicing-can-activate-antiviral-immune-pathways-in-triple-negative-breast-cancers.aspx)